![Ivan Bergstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Bergstein
Chief Executive Officer at
STEMLINE THERAPEUTICS, INC.
Profile
Ivan Bergstein is the founder of Stemline Therapeutics, Inc. (2003) as President & Chief Executive Officer.
Current job is at Lirum Therapeutics, Inc. as Chairman since 2021.
Former jobs include Medical Director at Keryx Biopharmaceuticals, Inc., Medical Director at ACCESS Oncology, Inc., and Senior Biopharmaceuticals Analyst at Nitron Advisors.
Education includes an undergraduate degree from the University of Pennsylvania and a doctorate from Icahn School of Medicine at Mount Sinai.
Ivan Bergstein active positions
| Companies | Position | Start |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Chief Executive Officer | - |
| LIRUM THERAPEUTICS, INC. | Chairman | 2021-10-31 |
Former positions of Ivan Bergstein
| Companies | Position | End |
|---|---|---|
Nitron Advisors
 Nitron Advisors Investment ManagersFinance Operates investment research company | Corporate Officer/Principal | - |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | - |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Chief Tech/Sci/R&D Officer | - |
Training of Ivan Bergstein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nitron Advisors
Nitron Advisors Investment ManagersFinance Operates investment research company | Finance |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
- Stock Market
- Insiders
- Ivan Bergstein
